121 related articles for article (PubMed ID: 34513052)
21. Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer.
Joergensen MT; Heegaard NH; Schaffalitzky de Muckadell OB
Pancreas; 2010 Mar; 39(2):243-7. PubMed ID: 19820423
[TBL] [Abstract][Full Text] [Related]
22. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
J Urol; 2008 Aug; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
[TBL] [Abstract][Full Text] [Related]
23. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas.
Eigenbrodt E; Basenau D; Holthusen S; Mazurek S; Fischer G
Anticancer Res; 1997; 17(4B):3153-6. PubMed ID: 9329624
[TBL] [Abstract][Full Text] [Related]
24. Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy.
Nisman B; Yutkin V; Nechushtan H; Gofrit ON; Peretz T; Gronowitz S; Pode D
Urology; 2010 Aug; 76(2):513.e1-6. PubMed ID: 20573390
[TBL] [Abstract][Full Text] [Related]
25. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer.
Ventrucci M; Cipolla A; Racchini C; Casadei R; Simoni P; Gullo L
Dig Dis Sci; 2004 Aug; 49(7-8):1149-55. PubMed ID: 15387337
[TBL] [Abstract][Full Text] [Related]
26. Tumor marker pyruvate kinase type tumor M2 in patients suffering from diabetic nephropathy.
Oremek GM; Rutner F; Sapoutzis N; Sauer-Eppel H
Anticancer Res; 2003; 23(2A):1155-8. PubMed ID: 12820364
[TBL] [Abstract][Full Text] [Related]
27. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
[TBL] [Abstract][Full Text] [Related]
28. Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients.
de la Taille A; Katz A; Cao Y; McKiernan J; Buttyan R; Burchardt M; Burchardt T; Hayek O; Olsson CA; Chopin DK; Sawczuk IS
Urology; 2000 Sep; 56(3):393-8. PubMed ID: 10962301
[TBL] [Abstract][Full Text] [Related]
29. Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors.
Gilbert SM; Whitson JM; Mansukhani M; Buttyan R; Benson MC; Olsson CA; Sawczuk IS; McKiernan JM
Urology; 2006 May; 67(5):942-5. PubMed ID: 16698354
[TBL] [Abstract][Full Text] [Related]
30. Determination of pyruvate kinase type tumor M2 in human renal cell carcinoma: a suitable tumor marker?
Varga Z; Hegele A; Stief T; Heidenreich A; Hofmann R
Urol Res; 2002 May; 30(2):122-5. PubMed ID: 12086017
[TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking.
Schweiger T; Kollmann D; Nikolowsky C; Traxler D; Guenova E; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Eur J Cardiothorac Surg; 2014 Jul; 46(1):92-9. PubMed ID: 24321995
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation.
Duivenvoorden WC; Hopmans SN; Gallino D; Farrell T; Gerdes C; Glennie D; Lukka H; Pinthus JH
Oncol Rep; 2015 Oct; 34(4):1968-76. PubMed ID: 26252502
[TBL] [Abstract][Full Text] [Related]
33. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma.
Choi SW; Kim JY; Park JY; Cha IH; Kim J; Lee S
Hum Pathol; 2008 Sep; 39(9):1317-22. PubMed ID: 18440050
[TBL] [Abstract][Full Text] [Related]
34. Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma.
Kim BR; Yang EK; Kim DY; Kim SH; Moon DC; Lee JH; Kim HJ; Lee JC
Clin Exp Immunol; 2012 Jan; 167(1):73-83. PubMed ID: 22132887
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase IX expression is associated with favorable prognostic factors in small intestinal carcinoma.
Gu MJ; Kwon KW
J Histochem Cytochem; 2014 Mar; 62(3):205-10. PubMed ID: 24217923
[TBL] [Abstract][Full Text] [Related]
36. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.
Hardt PD; Toepler M; Ngoumou B; Rupp J; Kloer HU
Anticancer Res; 2003; 23(2A):851-3. PubMed ID: 12820312
[TBL] [Abstract][Full Text] [Related]
37. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
Li G; Bilal I; Gentil-Perret A; Feng G; Zhao A; Peoc'h M; Genin C; Tostain J; Gigante M
Urol Oncol; 2012; 30(4):463-8. PubMed ID: 20822935
[TBL] [Abstract][Full Text] [Related]
38. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
[TBL] [Abstract][Full Text] [Related]
39. Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes.
Baniak N; Flood TA; Buchanan M; Dal Cin P; Hirsch MS
Histopathology; 2020 Oct; 77(4):659-666. PubMed ID: 32639054
[TBL] [Abstract][Full Text] [Related]
40. High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7.
Huber AR; Tan D; Sun J; Dean D; Wu T; Zhou Z
BMC Gastroenterol; 2015 Jul; 15():80. PubMed ID: 26156831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
